Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FXMP8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,889
Award facts
- Contract value 100% obligated
- $28,888.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) with a ceiling value of $28.9K. This is a non-set-aside competitive award with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical product that supports military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999.9M through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's competitively awarded contracts demonstrate its capability to meet federal procurement standards and support the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to ensure reliable pharmaceutical supply chains for military operations.
Quick answers
Who was awarded contract SPE2DB25FXMP8?
SPE2DB25FXMP8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FXMP8 worth?
The government has obligated $28,889 on SPE2DB25FXMP8.
Is contract SPE2DB25FXMP8 an order under another contract?
Yes. SPE2DB25FXMP8 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXMP8 competed?
The extent of competition for SPE2DB25FXMP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award